The increasing influence of limited dominant pharmaceutical companies is igniting serious concerns worldwide. This phenomenon towards control often results to escalated drug charges, limited progress, and difficulties in accessing critical medications for individuals throughout the world. Experts believe that stronger oversight is necessary to tack

India's pharmaceutical landscape presents a complex picture, largely shaped by the significant influence of a few prominent players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These traditional companies, including names like